成人脑干胶质瘤的2-羟基戊二酸磁共振波谱检查
本研究对10例成人脑干胶质瘤患者行3T 2HG-MRS检查并均经活检病理确诊,评估2HG-MRS诊断IDH突变型脑干胶质瘤的效用。结果显示2HG浓度≥1.8 mM对IDH突变型脑干胶质瘤的灵敏度为100%(95%CI 28%-100%)、特异度为100%(95%CI 42%-100%),p=0.0048。
要点
- 2HG浓度≥1.8 mM对IDH突变型成人脑干胶质瘤的灵敏度为100%(95%CI 28%-100%),特异度为100%(95%CI 42%-100%)。
- IDH野生型脑干胶质瘤患者(n=6)中位总生存期为10个月,IDH突变型患者(n=4)因死亡数少无法估计。
- H3K27M突变与IDH突变互斥,常规MRI序列上两者无显著影像学差异。
核心结论
- 2HG-MRS对预测IDH突变型脑干胶质瘤具有高灵敏度和特异度,并可能有助于预测成人脑干胶质瘤患者的预后。
研究设计与样本
- 对影像学确诊的脑干肿瘤患者行3T MRS检查,根据T2或FLAIR图像在病灶内设置单一体素,按2HG定制MRS协议(点解析波谱序列,回波时间35毫秒)分析。
- 所有患者均行术中导航引导或CT引导立体定向活检以获取组织病理学诊断,并通过免疫组化和直接DNA测序确认IDH与H3K27M突变状态。
- 共纳入10例患者(男7例,女3例;中位年龄33.5岁),并分析患者2HG浓度与生存时间的关系。
主要发现
- 4例患者有H3K27M突变,4例有IDH1突变(1例R132H典型IDH突变,2例R132S和1例R132G非典型IDH突变),2例既无H3K27M也无IDH突变。
- H3K27M突变与IDH突变互斥,多数肿瘤位于脑桥,突变型H3K27M与IDH在常规MRI序列上无显著影像学差异。
- MRS上2HG浓度≥1.8 mM对IDH突变型脑干胶质瘤的灵敏度为100%(95%CI 28%-100%),特异度为100%(95%CI 42%-100%),p=0.0048。
- IDH野生型脑干胶质瘤患者(n=6)的中位总生存期为10个月,IDH突变型脑干胶质瘤患者(n=4)因死亡数少无法估计中位总生存期,p=0.008。
关键数值与推荐
- 2HG浓度≥1.8 mM用于预测IDH突变型成人脑干胶质瘤:灵敏度100%(95%CI 28%-100%),特异度100%(95%CI 42%-100%),p=0.0048。
临床怎么用
- 原文结论指出2HG-MRS对预测IDH突变型脑干胶质瘤具有高灵敏度和特异度,并可能有助于预测成人脑干胶质瘤患者的预后。
局限性
- IDH突变型脑干胶质瘤患者(n=4)因死亡数少无法估计中位总生存期。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Adult brainstem gliomas (BSGs) are rare tumors of the CNS that are poorly understood. Upregulation of the oncometabolite 2-hydroxyglutarate (2HG) in the tumor indicates the mutation of isocitrate dehydrogenase (IDH), which can be detected by magnetic resonance spectroscopy (MRS). Although histological examination is required for the definitive diagnosis of BSG, 2HG-optimized MRS (2HG-MRS) may be useful, considering the difficult nature of brainstem lesion biopsy. The aim of this study was to evaluate the utility of 2HG-MRS for diagnosing IDH-mutant adult BSG. METHODS: Patients with a radiographically confirmed brainstem tumor underwent 3T MRS. A single voxel was set in the lesion with reference to the T2 or fluid-attenuated inversion recovery image and analyzed according to the 2HG-tailored MRS protocol (point-resolved spectroscopic sequence; echo time 35 msec). All patients underwent intraoperative navigation-guided or CT-guided stereotactic biopsy for histopathological diagnosis. The status of IDH and H3K27M mutations was confirmed by immunohistochemistry and direct DNA sequencing. In addition, the authors examined the relationship between patients' 2HG concentrations and survival time. RESULTS: Ten patients (7 men, 3 women; median age 33.5 years) underwent 2HG-MRS and biopsy. Four patients had an H3K27M mutation and 4 had an IDH1 mutation (1 R132H canonical IDH mutation, 2 R132S and 1 R132G noncanonical IDH mutations). Two had neither H3K27M nor IDH mutations. The H3K27M and IDH mutations were mutually exclusive. Most tumors were located in the pons. There was no significant radiological difference between mutant H3K27M and IDH on a conventional MRI sequence. A 2HG concentration ≥ 1.8 mM on MRS demonstrated 100% (95% CI 28%-100%) sensitivity and 100% (95% CI 42%-100%) specificity for IDH-mutant BSG (p = 0.0048). The median overall survival was 10 months in IDH-wild-type BSG patients (n = 6) and could not be estimated in IDH-mutant BSG patients (n = 4) due to the small number of deaths (p = 0.008). CONCLUSIONS: 2HG-MRS demonstrated high sensitivity and specificity for the prediction of IDH-mutant BSG. In addition, 2HG-MRS may be useful for predicting the prognosis of adult BSG patients.
引用
- Iwahashi H, Nagashima H, Tanaka K, et al. 2-Hydroxyglutarate magnetic resonance spectroscopy in adult brainstem glioma. J Neurosurg. 2023. PMID: 36708540. doi:10.3171/2022.12.JNS221954
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。